Ibrutinib Intermediate 1-Boc-3-hydroxypiperidine 143900-44-1
Ibrutinib Intermediates (S)-1-Boc-3-hydroxypiperidine 143900-44-1:
Product name: (S)-1-Boc-3-hydroxypiperidine
Cas Number: 143900-44-1
Moculer formula:C10H19NO3
Moculer weight: 201.263
Appearance: White powder
Assay(By HPLC): ≥99.0%
Ibrutinib (USAN, also known as PCI-32765 and marketed under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK).
Ibrutinib was developed by Pharmacyclics, Inc and Johnson & Johnson's Janssen Pharmaceutical division for additional B-cell malignancies including diffuse large B-cell lymphoma and multiple myeloma.
Our productions of Ibrutinib Intermediates:
Ibrutinib Intermediates (S)-1-Boc-3-hydroxypiperidine 143900-44-1:
Package & Shipping:
1. Preferentially DHL or FedEx for quantity less than 50KG; Air shipping fo…